Interview with Mike Felix, AT&T Alascom: nearly two years as president/CEO, this leader has a vision for his company and is making strides in accomplishing his goals.
Alaska Business Monthly › Vol. 19 Nbr. 10, October 2003
Linked as:
Alaska Business Monthly › Vol. 19 Nbr. 10, October 2003
Linked as:Summary
Interview - Interview
See the full content of this document
Extract
Interview with Mike Felix, AT&T Alascom: nearly two years as president/CEO, this leader has a vision for his company and is making strides in accomplishing his goals.
When Mike Felix took the helm of Anchorage-based AT&T Alascom early last year, his goal was simple: to re-establish the company as the leading telecommunications player in Alaska. Felix knew, however, the task was easier said than done.
Since AT&T's purchase of Alascom in 1995, the company had seen a sharp drop off in market share, revenue and profit, losing ground to younger and more agile competitors such as GCI and ACS. Felix attributed much of the decline to the widespread perception that Alascom, a company that has been serving Alaska for more than 100 years, had lost touch with the community. "People felt like we had withdrawn," said Felix. "Even though we had not actually withdrawn, perception became a reality and business followed companies that were better connected with the community." Namely, GCI. In response, ...See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
episcopalians to gather this weekend in dayton | Replay Fairmont Wins 3rd Straight District Title | Riches to Rags | exhibit examines building block of art | Sentencia nº 1949 de Consiglio di Stato, April 28, 2010 | Sentencia nº 4520 de Consiglio di Stato August 26 2008 | Sentencia nº 1077 de Consiglio di Stato, March 09, 2011 | COMUNICATO Variazione di tipo II all autorizzazione secondo procedura di mutuo riconoscimento del medicinale «Fludara» 11A05338